CollPlant Biotechnologies (CLGN) Market Capitalization (2018 - 2026)

CollPlant Biotechnologies (CLGN) has reported Market Capitalization for 9 consecutive years, with $755377.6 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Market Capitalization fell 74.14% year-over-year to $755377.6; the trailing twelve-month figure through Mar 2026 stood at $755377.6 (down 74.14% YoY), and the FY2025 full-year result was $1.8 million, down 56.53% from the prior year.
• Market Capitalization fell to $755377.6 in Q1 2026 per CLGN's latest filing, from $1.8 million in the prior quarter.
• Across five years, Market Capitalization topped out at $12.1 million in Q1 2022 and bottomed at $755377.6 in Q1 2026.
• Historically, Market Capitalization has averaged $5.9 million across 5 years, with a median of $6.1 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Market Capitalization increased 29.13% in 2022, then sank 74.14% in 2026.
• Over 5 years, Market Capitalization stood at $9.3 million in 2022, then slipped by 21.65% to $7.3 million in 2023, then tumbled by 43.65% to $4.1 million in 2024, then slumped by 56.53% to $1.8 million in 2025, then plunged by 57.86% to $755377.6 in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $755377.6, $1.8 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.